{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:28:08Z","timestamp":1787704088043,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/01910"],"award-info":[{"award-number":["PI23\/01910"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["PI23\/01910"],"award-info":[{"award-number":["PI23\/01910"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RD24\/0013\/0015"],"award-info":[{"award-number":["RD24\/0013\/0015"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-onset preeclampsia (eoPE), defined as preeclampsia occurring before 34 weeks of gestation, remains one of the leading causes of severe maternal morbidity, iatrogenic prematurity, and maternal mortality worldwide. Its heterogeneous and rapidly evolving clinical course makes the prediction of adverse outcomes particularly challenging. Although machine learning (ML)\u2013based models have shown promise in stratifying eoPE risk and supporting clinical decision-making, robust prospective external validation is still lacking. The present study aims to address this gap through a multicenter validation of three ML models previously developed by our group to: (1) predict maternal complications, (2) estimate the likelihood of delivery within \u2264\u20097 days of diagnosis, and (3) identify the risk of hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome or placental abruption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective multicenter cohort study (2024\u20132027) recruits pregnant women diagnosed with eoPE after informed consent. Clinical, analytical, and ultrasound data, including all variables used in the models, are recorded from early pregnancy to delivery. The first 100 cases will undergo quantitative external validation of three ML models and a semi-quantitative evaluation by clinicians, after which these cases will be used to retrain the models. The updated models will then be prospectively applied to the next 100 participants. Model predictions and physician\u00b4s assessment of the clinical utility of such predictions are generated through a secure web application accessible only after delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study addresses a critical gap in the prospective validation of ML-based tools for eoPE, emphasizing methodological rigor, data quality, and external validation in a multicenter setting. By integrating quantitative performance assessment with clinician-centered evaluation, the project seeks to ensure both statistical robustness and real-world clinical relevance. If successfully validated, these models could support more individualized and timely decision-making in eoPE management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09424-3","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:46:00Z","timestamp":1781156760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protocol for the external validation of machine learning models for risk prediction in early-onset preeclampsia: a multicenter prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2169-6011","authenticated-orcid":false,"given":"Paula","family":"Dom\u00ednguez-del Olmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4190-3180","authenticated-orcid":false,"given":"I\u00f1igo","family":"Melchor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4595-2219","authenticated-orcid":false,"given":"Esther","family":"C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2415-1626","authenticated-orcid":false,"given":"Pablo","family":"Garc\u00eda-Manau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8655-4722","authenticated-orcid":false,"given":"Marc Josep","family":"Cahuana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4019-0687","authenticated-orcid":false,"given":"Mar\u00eda","family":"P\u00e9rez-Marqu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-0737","authenticated-orcid":false,"given":"Elena","family":"Satorres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9367-6541","authenticated-orcid":false,"given":"Fernando","family":"Bugatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9456-4100","authenticated-orcid":false,"given":"Cecilia","family":"Villala\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Robisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7236-5330","authenticated-orcid":false,"given":"Jos\u00e9","family":"L Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-1474","authenticated-orcid":false,"given":"Alberto","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-4944","authenticated-orcid":false,"given":"Ignacio","family":"Herraiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"9424_CR1","unstructured":"De Paco Matallana K, Llurba Oliv\u00e9 E. Gu\u00eda de Asistencia Pr\u00e1ctica de la Sociedad Espa\u00f1ola de Ginecolog\u00eda y Obstetricia (SEGO): Trastornos hipertensivos de la gestaci\u00f3n. 2020. Available (with restrictions) at: https:\/\/sego.es\/Guias_de_Asistencia_Practica#perinatal."},{"key":"9424_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bpobgyn.2016.05.005","volume":"36","author":"P von Dadelszen","year":"2016","unstructured":"von Dadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;36:83\u2013102. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.05.005.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"9424_CR3","unstructured":"WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Trends in Maternal Mortality: 1990 to 2015. Geneva: World Health Organization. 2015. Available at: https:\/\/www.unfpa.org\/publications\/trends-maternal-mortality-1990-2015."},{"issue":"1","key":"9424_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/01.AOG.0000266977.26311.f0","volume":"110","author":"J Menzies","year":"2007","unstructured":"Menzies J, Magee LA, Li J, MacNab YC, Yin R, Stuart H, et al. Preeclampsia Integrated Estimate of RiSk (PIERS) Study Group. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol. 2007;110(1):121\u20137. https:\/\/doi.org\/10.1097\/01.AOG.0000266977.26311.f0.","journal-title":"Obstet Gynecol"},{"issue":"19","key":"9424_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"LA Magee","year":"2022","unstructured":"Magee LA, Nicolaides KH, von Dadelszen P, Preeclampsia. N Engl J Med. 2022;386(19):1817\u201332. https:\/\/doi.org\/10.1056\/NEJMra2109523.","journal-title":"N Engl J Med"},{"issue":"3","key":"9424_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.semperi.2014.03.006","volume":"38","author":"AM Vintzileos","year":"2014","unstructured":"Vintzileos AM, Ananth CV. First trimester prediction of ischemic placental disease. Semin Perinatol. 2014;38(3):159\u201366. https:\/\/doi.org\/10.1053\/j.semperi.2014.03.006.","journal-title":"Semin Perinatol"},{"issue":"4","key":"9424_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/AOG.0000000000000472","volume":"124","author":"S Lisonkova","year":"2014","unstructured":"Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol. 2014;124(4):771\u201381. https:\/\/doi.org\/10.1097\/AOG.0000000000000472.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"9424_CR8","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1373\/clinchem.2011.169094","volume":"58","author":"H Hagmann","year":"2012","unstructured":"Hagmann H, Thadhani R, Benzing T, Karumanchi SA, Stepan H. The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem. 2012;58(5):837\u201345. https:\/\/doi.org\/10.1373\/clinchem.2011.169094.","journal-title":"Clin Chem"},{"issue":"5","key":"9424_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649\u201358. https:\/\/doi.org\/10.1172\/JCI17189.","journal-title":"J Clin Invest"},{"issue":"1","key":"9424_CR10","doi-asserted-by":"publisher","first-page":"e581","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206(1):e581\u20138. https:\/\/doi.org\/10.1016\/j.ajog.2011.07.037.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"9424_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11906-020-01082-w","volume":"22","author":"RG Sinkey","year":"2020","unstructured":"Sinkey RG, Battarbee AN, Bello NA, Ives CW, Oparil S, Tita ATN. Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines. Curr Hypertens Rep. 2020;22(9):66. https:\/\/doi.org\/10.1007\/s11906-020-01082-w.","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"9424_CR12","doi-asserted-by":"publisher","first-page":"CD003106","DOI":"10.1002\/14651858.CD003106.pub3","volume":"10","author":"D Churchill","year":"2018","unstructured":"Churchill D, Duley L, Thornton JG, Moussa M, Ali HS, Walker KF. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks\u2019 gestation. Cochrane Database Syst Rev. 2018;10(10):CD003106. https:\/\/doi.org\/10.1002\/14651858.CD003106.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"9424_CR13","doi-asserted-by":"publisher","first-page":"910701","DOI":"10.3389\/fcvm.2022.910701","volume":"9","author":"C Villala\u00edn","year":"2022","unstructured":"Villala\u00edn C, Herraiz I, Dom\u00ednguez-Del Olmo P, Angulo P, Ayala JL, Galindo A. Prediction of Delivery Within 7 Days After Diagnosis of Early Onset Preeclampsia Using Machine-Learning Models. Front Cardiovasc Med. 2022;9:910701. https:\/\/doi.org\/10.3389\/fcvm.2022.910701.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"9424_CR14","first-page":"1070","volume":"76","author":"HJ Odendaal","year":"1990","unstructured":"Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28\u201334 weeks\u2019 gestation: a randomized controlled trial. Obstet Gynecol. 1990;76(6):1070\u20135.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"9424_CR15","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-x","volume":"171","author":"BM Sibai","year":"1994","unstructured":"Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks\u2019 gestation: a randomized controlled trial. Am J Obstet Gynecol. 1994;171(3):818\u201322. https:\/\/doi.org\/10.1016\/0002-9378(94)90104-x.","journal-title":"Am J Obstet Gynecol"},{"key":"9424_CR16","doi-asserted-by":"publisher","unstructured":"Ancel PY, Goffinet F, EPIPAGE-2 Writing Group. Survival and morbidity of preterm children born at 22 through 34 weeks\u2019 gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015;169(3):230-8. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3351 . Erratum in: JAMA Pediatr. 2015;169(4):323. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.0528 .","DOI":"10.1001\/jamapediatrics.2015.0528"},{"issue":"1","key":"9424_CR17","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajog.2016.01.004","volume":"215","author":"TA Manuck","year":"2016","unstructured":"Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, et al. Preterm neonatal morbidity and mortality by gestational age: a contemporary cohort. Am J Obstet Gynecol. 2016;215(1):103. https:\/\/doi.org\/10.1016\/j.ajog.2016.01.004.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"9424_CR18","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.1503\/cmaj.190940","volume":"192","author":"SK Lee","year":"2020","unstructured":"Lee SK, Beltempo M, McMillan DD, Seshia M, Singhal N, Dow K, et al. Outcomes and care practices for preterm infants born at less than 33 weeks\u2019 gestation: a quality- improvement study. CMAJ. 2020;192(4):E81\u201391. https:\/\/doi.org\/10.1503\/cmaj.190940.","journal-title":"CMAJ"},{"issue":"6","key":"9424_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/AOG.0000000000000840","volume":"125","author":"N Melamed","year":"2015","unstructured":"Melamed N, Shah J, Soraisham A, Yoon EW, Lee SK, Shah PS, Murphy KE. Association Between Antenatal Corticosteroid Administration-to-Birth Interval and Outcomes of Preterm Neonates. Obstet Gynecol. 2015;125(6):1377\u201384. https:\/\/doi.org\/10.1097\/AOG.0000000000000840.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"9424_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0042-1760386","volume":"41","author":"K Ninan","year":"2024","unstructured":"Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD. Long-Term Outcomes of Multiple versus a Single Course of Antenatal Steroids: A Systematic Review. Am J Perinatol. 2024;41(4):395\u2013404. https:\/\/doi.org\/10.1055\/s-0042-1760386.","journal-title":"Am J Perinatol"},{"issue":"6","key":"9424_CR21","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2022.02.021","volume":"226","author":"RF Hamm","year":"2022","unstructured":"Hamm RF, Combs CA, Aghajanian P, Friedman AM, Patient Safety and Quality Committee. Society for Maternal-Fetal Medicine Special Statement: Quality metrics for optimal timing of antenatal corticosteroid administration. Am J Obstet Gynecol. 2022;226(6):B2\u201310. https:\/\/doi.org\/10.1016\/j.ajog.2022.02.021.","journal-title":"Am J Obstet Gynecol"},{"key":"9424_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.preghy.2022.10.006","volume":"30","author":"A Hurrell","year":"2022","unstructured":"Hurrell A, Busuulwa P, Webster L, Duhig K, Seed PT, Chappell LC, Shennan AH. Optimising timing of steroid administration in preterm pre-eclampsia. Pregnancy Hypertens. 2022;30:177\u201380. https:\/\/doi.org\/10.1016\/j.preghy.2022.10.006.","journal-title":"Pregnancy Hypertens"},{"issue":"6","key":"9424_CR23","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00404-022-06864-y","volume":"308","author":"M Hackel\u00f6er","year":"2023","unstructured":"Hackel\u00f6er M, Schmidt L, Verlohren S. New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring. Arch Gynecol Obstet. 2023;308(6):1663\u201377. https:\/\/doi.org\/10.1007\/s00404-022-06864-y.","journal-title":"Arch Gynecol Obstet"},{"issue":"Suppl 1","key":"9424_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s13224-015-0779-5","volume":"66","author":"S Agrawal","year":"2016","unstructured":"Agrawal S, Maitra N. Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model. J Obstet Gynaecol India. 2016;66(Suppl 1):104\u201311. https:\/\/doi.org\/10.1007\/s13224-015-0779-5.","journal-title":"J Obstet Gynaecol India"},{"issue":"4","key":"9424_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/HYPERTENSIONAHA.116.08706","volume":"69","author":"UV Ukah","year":"2017","unstructured":"Ukah UV, Payne B, Lee T, Magee LA, von Dadelszen P. fullPIERS and miniPIERS Working Groups. External Validation of the fullPIERS Model for Predicting Adverse Maternal Outcomes in Pregnancy Hypertension in Low- and Middle-Income Countries. Hypertension. 2017;69(4):705\u201311. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.116.08706.","journal-title":"Hypertension"},{"key":"9424_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejogrb.2014.05.021","volume":"179","author":"J Akkermans","year":"2014","unstructured":"Akkermans J, Payne B, von Dadelszen P, Groen H, Vries Jd, Magee LA, et al. Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset. Eur J Obstet Gynecol Reprod Biol. 2014;179:58\u201362. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.05.021.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9424_CR27","doi-asserted-by":"publisher","first-page":"e","DOI":"10.61622\/rbgo\/2025rbgo39","volume":"47","author":"I Gomes","year":"2025","unstructured":"Gomes I, Mar\u00e7al F, Reis JVC, Silva APDS, Sampaio L, Moreira LA, et al. The accuracy of the fullPIERS model in predicting adverse maternal and perinatal outcomes: evidence from a tertiary care maternity unit. Rev Bras Ginecol Obstet. 2025;47:e\u2013rbgo39. https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo39.","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"9424_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.117.10318","volume":"71","author":"UV Ukah","year":"2018","unstructured":"Ukah UV, Payne B, Hutcheon JA, Ansermino JM, Ganzevoort W, Thangaratinam S, et al. Assessment of the fullPIERS Risk Prediction Model in Women With Early-Onset Preeclampsia. Hypertension. 2018;71(4):659\u201365. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10318.","journal-title":"Hypertension"},{"issue":"9761","key":"9424_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","volume":"377","author":"P von Dadelszen","year":"2011","unstructured":"von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, C\u00f4t\u00e9 AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet. 2011;377(9761):219\u201327. https:\/\/doi.org\/10.1016\/S0140-6736(10)61351-7.","journal-title":"Lancet"},{"key":"9424_CR30","doi-asserted-by":"publisher","first-page":"174550572513489","DOI":"10.1177\/17455057251348978","volume":"21","author":"P Dom\u00ednguez Del Olmo","year":"2025","unstructured":"Dom\u00ednguez Del Olmo P, Herraiz I, Villala\u00edn C, Galindo A, Ayala JL. Predictive modeling of complications arising from early-onset preeclampsia in pregnant women. Womens Health (Lond). 2025;21:17455057251348978. . https:\/\/doi.org\/10.1177\/17455057251348978","journal-title":"Womens Health (Lond)"},{"key":"9424_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","volume":"27","author":"LA Magee","year":"2022","unstructured":"Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27:148\u201369. https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008.","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"9424_CR32","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","volume":"63","author":"S Verlohren","year":"2014","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, et al. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014;63(2):346\u201352. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01787.","journal-title":"Hypertension"},{"issue":"2","key":"9424_CR33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"key":"9424_CR34","doi-asserted-by":"publisher","unstructured":"Stekhoven DJ, B\u00fchlmann P. data Bioinf. 2012;28(1):112\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597. MissForest\u2014non-parametric missing value imputation for mixed-type.","DOI":"10.1093\/bioinformatics\/btr597"},{"issue":"9","key":"9424_CR35","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s11517-022-02630-z","volume":"60","author":"F Garc\u00eda-Gutierrez","year":"2022","unstructured":"Garc\u00eda-Gutierrez F, D\u00edaz-\u00c1lvarez J, Matias-Guiu JA, Pytel V, Mat\u00edas-Guiu J, Cabrera-Mart\u00edn MN, Ayala JL. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer\u2019s disease and frontotemporal dementia using genetic algorithms. Med Biol Eng Comput. 2022;60(9):2737\u201356. https:\/\/doi.org\/10.1007\/s11517-022-02630-z.","journal-title":"Med Biol Eng Comput"},{"issue":"2","key":"9424_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41390-022-02181-x","volume":"93","author":"M Pammi","year":"2023","unstructured":"Pammi M, Aghaeepour N, Neu J. Multiomics, artificial intelligence, and precision medicine in perinatology. Pediatr Res. 2023;93(2):308\u201315. https:\/\/doi.org\/10.1038\/s41390-022-02181-x.","journal-title":"Pediatr Res"},{"issue":"46","key":"9424_CR37","doi-asserted-by":"publisher","first-page":"4831","DOI":"10.1093\/eurheartj\/ehad727","volume":"44","author":"FS van Royen","year":"2023","unstructured":"van Royen FS, Asselbergs FW, Alfonso F, Vardas P, van Smeden M. Five critical quality criteria for artificial intelligence-based prediction models. Eur Heart J. 2023;44(46):4831\u20134. https:\/\/doi.org\/10.1093\/eurheartj\/ehad727.","journal-title":"Eur Heart J"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09424-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09424-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09424-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:10:32Z","timestamp":1787703032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09424-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9424"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09424-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study protocol was approved by the Ethics Committee of the Hospital Universitario 12 de Octubre in Madrid (N\u00ba CEIm 24\/386) on 12th December 2024. Participants, and their partners when applicable, are provided with both verbal and written explanations of the purpose of the study. Once the candidate shows her intention to participate, written informed consent will be obtained in the presence of an investigator, who ensures that the study is explained in clear and accessible language, adhering to the Declaration of Helsinki. The signed document will then be stored in paper format within the department for potential future verification, and the participant will be formally enrolled.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"951"}}